Hong Wan

Papers

Total Citations

H-Index

About

Hong Wan is a distinguished pharmaceutical scientist whose work has significantly advanced early-stage drug discovery, particularly through the integration of high-throughput screening and in vitro ADME (absorption, distribution, metabolism, and excretion) profiling. Her key research areas include physicochemical property optimization, pharmacokinetics, and the development of automated, LC-MS-based assays for rapid compound evaluation. Wan’s seminal 2009 review, “High Throughput Screening of Physicochemical Properties and In Vitro ADME Profiling in Drug Discovery,” has garnered 97 citations, reflecting its foundational role in shaping modern preclinical workflows. In this work, she systematically summarized how robotic automation combined with sensitive liquid chromatography-mass spectrometry enables the high-speed screening of lead series libraries—a breakthrough that has helped pharmaceutical teams identify promising drug candidates earlier and more efficiently. By bridging the gap between chemical synthesis and biological testing, Wan’s contributions have accelerated the drug development pipeline, reducing attrition rates due to poor ADME properties. Her research continues to influence the design of robust, high-capacity screening platforms, making her a pivotal figure in the evolution of rational drug design and translational pharmaceutical science.